These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25972597)

  • 1. Imatinib for sclerodermatous graft-versus-host disease in lung transplantation.
    Zhang J; Chen F; Ueki T; Date H
    Interact Cardiovasc Thorac Surg; 2015 Aug; 21(2):260-2. PubMed ID: 25972597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerodermatous Chronic Graft-versus-Host Disease Treated With Imatinib: A Dermatological Perspective.
    Molés-Poveda P; Montesinos P; Sanz-Caballer J; de Unamuno B; Piñana JL; Sahuquillo A; Botella-Estrada R
    Actas Dermosifiliogr (Engl Ed); 2018 Apr; 109(3):241-247. PubMed ID: 29254596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease.
    Belle L; Fransolet G; Somja J; Binsfeld M; Delvenne P; Drion P; Hannon M; Beguin Y; Ehx G; Baron F
    PLoS One; 2016; 11(12):e0167997. PubMed ID: 27942010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imatinib as a potential treatment for sclerodermatous chronic graft-vs-host disease.
    Moreno-Romero JA; Fernández-Avilés F; Carreras E; Rovira M; Martínez C; Mascaró JM
    Arch Dermatol; 2008 Sep; 144(9):1106-9. PubMed ID: 18794453
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD.
    Magro L; Catteau B; Coiteux V; Bruno B; Jouet JP; Yakoub-Agha I
    Bone Marrow Transplant; 2008 Dec; 42(11):757-60. PubMed ID: 18762765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD.
    de Masson A; Bouaziz JD; Peffault de Latour R; Wittnebel S; Ribaud P; Rubio MT; Micol JB; Suarez F; Nguyen S; Dalle JH; Yakouben K; Robin M; Xhaard A; Adès L; Bourhis JH; Rybojad M; Bagot M; Socié G
    Blood; 2012 Dec; 120(25):5089-90. PubMed ID: 23243159
    [No Abstract]   [Full Text] [Related]  

  • 7. Dasatinib as salvage therapy for steroid refractory and imatinib resistant or intolerant sclerotic chronic graft-versus-host disease.
    Sánchez-Ortega I; Servitje O; Arnan M; Ortí G; Peralta T; Manresa F; Duarte RF
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):318-23. PubMed ID: 22068151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined inhibition of c-Abl and PDGF receptors for prevention and treatment of murine sclerodermatous chronic graft-versus-host disease.
    Zerr P; Distler A; Palumbo-Zerr K; Tomcik M; Vollath S; Dees C; Egberts F; Tinazzi I; Del Galdo F; Distler O; Schett G; Spriewald BM; Distler JH
    Am J Pathol; 2012 Nov; 181(5):1672-80. PubMed ID: 22940072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib: A New Tool for the Management of Chronic Sclerodermatous Graft-Vs-Host Disease.
    Ferrándiz-Pulido C
    Actas Dermosifiliogr (Engl Ed); 2018 Apr; 109(3):200-201. PubMed ID: 29429550
    [No Abstract]   [Full Text] [Related]  

  • 10. Limited efficacy of imatinib in severe pulmonary chronic graft-versus-host disease.
    Stadler M; Ahlborn R; Kamal H; Diedrich H; Buchholz S; Eder M; Ganser A
    Blood; 2009 Oct; 114(17):3718-9; author reply 3719-20. PubMed ID: 19850751
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of sclerodermatous graft-versus-host disease responsive to imatinib therapy.
    Lazar J; Poonawalla T; Teng JM
    Pediatr Dermatol; 2011; 28(2):172-5. PubMed ID: 21504445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary disease as the chief manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation].
    Ohtaka M; Suzuki A; Gotoh A; Nagasu M; Torii Y; Kimura Y; Ichinose Y; Toyama K; Serizawa H; Ebihara Y
    Rinsho Ketsueki; 1993 Feb; 34(2):153-8. PubMed ID: 8492413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
    Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute graft-versus-host disease following lung transplantation in a patient with a novel
    Brestoff JR; Vessoni AT; Brenner KA; Uy GL; DiPersio JF; Blinder M; Witt CA; Byers DE; Hachem RR; Truclock EP; Early DS; Anadkat MJ; Musiek A; Javidan-Nejad C; Balfe DM; Rosman IS; Liu C; Zhang L; Despotis GJ; Ruzinova MB; Sehn JK; Amarillo I; Heusel JW; Swat W; Kim BS; Wartman LD; Yusen RD; Batista LFZ
    Thorax; 2018 May; 73(5):489-492. PubMed ID: 29382801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of pulmonary fibrosis for twenty weeks with imatinib mesylate in a patient with mixed connective tissue disease.
    Distler JH; Manger B; Spriewald BM; Schett G; Distler O
    Arthritis Rheum; 2008 Aug; 58(8):2538-42. PubMed ID: 18668536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
    DeAngelo DJ; Hochberg EP; Alyea EP; Longtine J; Lee S; Galinsky I; Parekkedon B; Ritz J; Antin JH; Stone RM; Soiffer RJ
    Clin Cancer Res; 2004 Aug; 10(15):5065-71. PubMed ID: 15297408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial pneumonitis, pulmonary fibrosis, and chronic graft-versus-host disease.
    Kaplan EB; Pietra GG; August CS
    Bone Marrow Transplant; 1992 Jan; 9(1):71-5. PubMed ID: 1543954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An acute pulmonary syndrome possibly representing acute graft-versus-host disease involving the lung interstitium.
    Atkinson K; Turner J; Biggs JC; Dodds A; Concannon A
    Bone Marrow Transplant; 1991 Sep; 8(3):231-4. PubMed ID: 1958905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive interstitial fibrosis of the lung in sclerodermoid chronic graft-versus-host disease.
    Wolff D; Reichenberger F; Steiner B; Kahl C; Leithäuser M; Skibbe T; Friedrich T; Terpe H; Helbig W; Freund M
    Bone Marrow Transplant; 2002 Feb; 29(4):357-60. PubMed ID: 11896434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sclerodermatous chronic graft-versus-host disease--a report of four pediatric cases.
    Tolland JP; Devereux C; Jones FC; Bingham EA
    Pediatr Dermatol; 2008; 25(2):240-4. PubMed ID: 18429789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.